Evidence map›Paper›PMID 40717084›Full record

ArticlePediatric rheumatology online journal2025

Mevalonate kinase deficiency: genetic and clinical characteristics of a Chinese pediatric cohort.

Chenchen Guan, Wenjie Wang, Qinhua Zhou, Jinqiao Sun, Lipin Liu, Luyao Liu, Bijun Sun, Jia Hou, Xiaochuan Wang

Abstract read
In one paragraph

Article in Pediatric rheumatology online journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chenchen GuanDepartment of Clinical Immunology and Allergy, Children's Hospital of Fudan University, 399 Wanyuan Road, Shanghai, 201102, China.
Wenjie WangDepartment of Clinical Immunology and Allergy, Children's Hospital of Fudan University, 399 Wanyuan Road, Shanghai, 201102, China.
Qinhua ZhouDepartment of Clinical Immunology and Allergy, Children's Hospital of Fudan University, 399 Wanyuan Road, Shanghai, 201102, China.
Jinqiao SunDepartment of Clinical Immunology and Allergy, Children's Hospital of Fudan University, 399 Wanyuan Road, Shanghai, 201102, China.
Lipin LiuDepartment of Clinical Immunology and Allergy, Children's Hospital of Fudan University, 399 Wanyuan Road, Shanghai, 201102, China.
Luyao LiuDepartment of Clinical Immunology and Allergy, Children's Hospital of Fudan University, 399 Wanyuan Road, Shanghai, 201102, China.
Bijun SunDepartment of Clinical Immunology and Allergy, Children's Hospital of Fudan University, 399 Wanyuan Road, Shanghai, 201102, China. sunbijun1990@163.com.
Jia HouDepartment of Clinical Immunology and Allergy, Children's Hospital of Fudan University, 399 Wanyuan Road, Shanghai, 201102, China. doctorhoujia@hotmail.com.
Xiaochuan WangDepartment of Clinical Immunology and Allergy, Children's Hospital of Fudan University, 399 Wanyuan Road, Shanghai, 201102, China. xchwang@shmu.edu.cn.

Funding

the "Sailing Program" of Shanghai Science and Technology Committee 23YF1403400the Shanghai Municipal Science and Technology Major Project ZD2021CY001
6 · The paper itself

Abstract

backgroundMevalonate kinase deficiency (MKD) is a rare autoinflammatory disease, and mevalonic aciduria (MA) is a severe phenotype of MKD. The present study reports the characteristics of MKD and four novel mutations in the mevalonate kinase (MVK) gene in a Chinese cohort.

methodA retrospective study was conducted on patients diagnosed with MKD from July 2013 to December 2024. The clinical, immunological, and follow-up data were collected from electronic medical records. Next-generation sequencing and Sanger sequencing were performed to identify gene mutations. A literature review was performed on MKD patients to further investigate the associations between genotype and phenotype.

resultsEleven MKD patients were enrolled from a Chinese cohort of prolonged and recurrent fever of unknown origin. Ten patients were classified as having hyperimmunoglobulin D syndrome (HIDS), and one patient was classified as having MA. The median follow-up duration was 5 years (IQR: 1.5-6 years). Recurrent fever and gastrointestinal symptoms were the most common symptoms. Anemia was observed in 8 of the 11 patients, including one patient with severe hematological complications. Growth restriction (5/11 patients) and developmental delay (4/11 patients) were also observed. IgD levels were measured in ten patients, and the median IgD level was 85.23 µg/ml (IQR: 18.74-385.19 µg/ml). Four novel mutation sites in the MVK gene were discovered: c.78G > A, c.463G > A, c.1076C > T and c.1088G > A. Etanercept was the effective biological agent tested, leading to complete or partial remission in 5 of the 6 patients. A literature review of 20 MA patients suggested that homozygous MVK gene mutations are more frequently associated with MA. Moreover, MA patients with the homozygous A334T mutation present a milder phenotype, and those with the I268T homozygous mutation present a more severe phenotype.

conclusionsThis study is the largest case series of MKD pediatric patients from China. Four new mutation sites in MVK were identified, further expanding the phenotypic and genotypic spectrum of MKD and emphasizing the significance of MVK mutation patterns in influencing disease severity.

Indexed as

Mevalonate Kinase DeficiencyPhosphotransferases (Alcohol Group Acceptor)AdolescentChildChild, PreschoolChinaEast Asian PeopleFemaleHumansInfantMaleMutationPhenotypeRetrospective Studiesmevalonate kinasePhosphotransferases (Alcohol Group Acceptor)Autoinflammatory disorderHyperimmunoglobulin D syndromeMevalonate kinase deficiencyMevalonic aciduria

Identifiers

PMID40717084
PMCPMC12297814

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.